Nature communications · 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zuljan Erika, von der Emde Benjamin, Piwonski Iris, Pestana Ana, Klinghammer Konrad, Mock Andreas, Horak Peter, Heining Christoph, Klauschen Frederick, Pretzell Ina, Boerries Melanie, Brandts Christian H, Kreutzfeldt Simon, Teleanu Maria-Veronica, Hübschmann Daniel, Morris Luc G T, Heiland Max, Keller Ulrich, Conrad Thomas, Glimm Hanno, Fröhling Stefan, Ochsenreither Sebastian, Keilholz Ulrich, Blanc Eric, Beule Dieter, Rieke Damian T
Аннотация
Salivary gland cancers are rare, diverse malignancies characterized by poor response to immunotherapy. The tumor immune environment in these cancers remains poorly understood. To address this, we perform an integrative analysis of the tumor immune microenvironment in a large cohort of advanced salivary gland cancer samples. Most tumors exhibit low immune activity with limited immune cell infiltration. Inflammation is linked to higher tumor mutational burden in non-adenoid cystic carcinoma histologies. Subtype specific expression of immune checkpoints is identified with prominent expression of VTCN1 in luminal-like cells within adenoid cystic carcinoma. Macrophages with immunosuppressive properties dominate the immune microenvironment across subtypes. Responses to immunotherapy are limited and associated with a higher ratio of T-cells relative to macrophages in individual cases, warranting further investigation. Here, we show an immunosuppressive environment in salivary gland cancers and identify subtype-specific immune vulnerabilities that could inform tailored therapeutic strategies.